Preventing acute kidney injury and its longer-term impact in the critically ill
Intensive Care Medicine · 2025-07 · 51 (7) · 1331-1347
DOI: 10.1007/s00134-025-08015-8 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Intensive Care Medicine, online erschienen am 15.07.2025. Verfasst von Alexander Zarbock und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Anesthesiology, Intensive Care and Pain Medicine, University Hospital Münster, Münster, Germany. zarbock@uni-muenster.de. Hauptthemen laut MEDLINE: Acute Kidney Injury, Critical Illness. Die Arbeit wurde bisher 30-mal zitiert (Crossref) und nennt 99 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Deutsche Forschungsgemeinschaft, Universitätsklinikum Münster.
Abstract (Originalsprache)
Acute kidney injury (AKI) is a heterogeneous syndrome that not only affects short-term morbidity and mortality but also influences long-term outcomes. AKI is part of acute kidney disease (AKD) that encompasses a range of different conditions and is characterized by a kidney dysfunction lasting 90 days or less after which time the term chronic kidney disease (CKD) applies. AKD may result in irreversible loss of nephrons and may lead to CKD. In this narrative review, an update on different aspects of AKI in critically ill patients will be provided. We discuss biomarkers for early diagnosis of AKI, sub-clinical AKI, as well as AKI-AKD-CKD transition. In addition, various strategies to prevent the development of AKI, including the application of amino acids, remote-ischemic preconditioning, hemoadsorption, and a kidney prevention strategy, will be discussed. Finally, the choice of adequate endpoints for AKI prevention trials will be addressed."Take home message".AKI and even subclinical AKI impact short- and long-term outcome and therefore, prevention of kidney injury is of utmost importance. As several strategies have been proven to be effective in preventing the development of AKI, these therapies should be implemented in daily practice to improve patient outcomes.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Anesthesiology, Intensive Care and Pain Medicine, University Hospital Münster, Münster, Germany. zarbock@uni-muenster.de.
- Department of Anesthesiology, Critical Care and Pain Medicine, McGovern Medical School, the University of Texas Health Science Center at Houston, Houston, USA. zarbock@uni-muenster.de.
- School of Medicine, University of Surrey and Royal Surrey Hospital, Guildford, Surrey, UK.
- Section of Nephrology, Department of Medicine, University of Chicago, Chicago, USA.
- Center for Critical Care Nephrology, University of Pittsburgh, Pittsburgh, USA.
- Division of Nephrology, Department of Medicine, Faculty of Medicine and Dentistry, University of Alberta, Edmonton, Canada.
ORCID-Profile: Alexander Zarbock
Förderung
- Deutsche Forschungsgemeinschaft
- Universitätsklinikum Münster
Zitieren
APA
Zarbock, A., Forni, L., Koyner, J. L., Gómez, H., Pannu, N., Ostermann, M., Bellomo, R., Kellum, J. A., & von Groote, T. (2025). Preventing acute kidney injury and its longer-term impact in the critically ill. Intensive Care Medicine, 51(7), 1331-1347. https://doi.org/10.1007/s00134-025-08015-8
Vancouver
Zarbock A, Forni L, Koyner JL, Gómez H, Pannu N, Ostermann M, et al. Preventing acute kidney injury and its longer-term impact in the critically ill. Intensive Care Medicine. 2025;51(7):1331-1347. doi:10.1007/s00134-025-08015-8
BibTeX
@article{Zarbock2025,
author = {Zarbock, Alexander and Forni, Lui and Koyner, Jay L and Gómez, Hernando and Pannu, Neesh and Ostermann, Marlies and Bellomo, Rinaldo and Kellum, John A and von Groote, Thilo},
title = {Preventing acute kidney injury and its longer-term impact in the critically ill},
journal = {Intensive Care Medicine},
year = {2025},
volume = {51},
number = {7},
pages = {1331--1347},
doi = {10.1007/s00134-025-08015-8}
}
EUVIMED